Syllabus for Proteomics for Drug Discovery

Proteomik för läkemedelsutveckling


  • 7.5 credits
  • Course code: 3FF031
  • Education cycle: Second cycle
  • Main field(s) of study and in-depth level: Pharmaceutical Sciences A1N, Drug Discovery and Development A1N

    Explanation of codes

    The code indicates the education cycle and in-depth level of the course in relation to other courses within the same main field of study according to the requirements for general degrees:

    First cycle

    • G1N: has only upper-secondary level entry requirements
    • G1F: has less than 60 credits in first-cycle course/s as entry requirements
    • G1E: contains specially designed degree project for Higher Education Diploma
    • G2F: has at least 60 credits in first-cycle course/s as entry requirements
    • G2E: has at least 60 credits in first-cycle course/s as entry requirements, contains degree project for Bachelor of Arts/Bachelor of Science
    • GXX: in-depth level of the course cannot be classified

    Second cycle

    • A1N: has only first-cycle course/s as entry requirements
    • A1F: has second-cycle course/s as entry requirements
    • A1E: contains degree project for Master of Arts/Master of Science (60 credits)
    • A2E: contains degree project for Master of Arts/Master of Science (120 credits)
    • AXX: in-depth level of the course cannot be classified

  • Grading system: Fail (U), Pass (G), Pass with distinction (VG)
  • Established: 2019-08-29
  • Established by:
  • Revised: 2022-08-25
  • Revised by: The Educational Board of Pharmacy
  • Applies from: Autumn 2023
  • Entry requirements:

    150 credits in biomedicine, pharmaceutical science, chemistry, drug development, natural science and/or technology. Proficiency in English equivalent to the Swedish upper secondary course English 6.

  • Responsible department: Department of Pharmaceutical Biosciences

Decisions and guidelines

The course is part of Master's Programme in Biopharmaceuticals. The course can be taken as a stand-alone course or elective within a program. The course is elective within the Master of Science Program in Pharmacy and the Master's Programme in Drug Discovery and Development.

Learning outcomes

Upon completion of the course, the student should be able to:

  • Identify, explain and motivate the use of mass spectrometry as a tool for development of biological drugs in preclinical and clinical phase.
  • Identify, explain and motivate the choice of analytical separation techniques coupled to mass spectrometry as function of sample type.
  • Design strategies for identification of target proteins and lead compounds for drug development with proteomic methods.
  • Use basic sample preparation and analysis techniques for proteomic studies.
  • Apply bioinformatics methods for analysis of qualitative and quantitative data from proteomic studies and account for background, methods and results in a scientific report written with technical language in Swedish or English.


The course covers analytical methods for proteomic measurements during the drug development process. Identification of target protein for drug design and evaluation of lead compounds with proteomic methods. Training of experimental skills include one week of experimental laboratory work with sample preparation, measurements with mass spectrometry and data analysis.


Instruction is provided through lectures, experimental exercises, seminars, oral and written presentations, and self-education with course curriculum literature. Proficiency is achieved through writing of a personal experimental protocol, one week of experimental work with a proteomic study using mass spectrometry including data analysis, summarized in a written report and oral presentation.

Compulsory requirements: experimental exercises, seminars, written scientific report including oral presentation of results. This course is given in English if so required.


Written examination at the end of the course. Written and oral presentation of experimental exercises. To pass the course, the student must pass the written examination (3 credits), and pass the compulsory requirements (3 credits for experimental exercises and 1.5 credits for seminars). Completion of compulsory parts of the course may be done at the earliest at the next course and then only if there is a vacancy.

If there are special reasons for doing so, an examiner may make an exception from the method of assessment indicated and allow a student to be assessed by another method. An example of special reasons might be a certificate regarding special pedagogical support from the University's disability coordinator.

Reading list

Reading list

Applies from: Autumn 2023

Some titles may be available electronically through the University library.